Tiagabine Hydrochloride 16 mg/1

Tiagabine Hydrochloride 16 mg tablets are a medication used to manage certain neurological conditions. This film-coated tablet is manufactured by Teva Pharmaceuticals USA, Inc. and is available in a 30-tablet bottle.

Tiagabine Hydrochloride is primarily used as an adjunctive therapy for the treatment of partial seizures in adults. It works by affecting the neurotransmitter GABA, which helps to reduce abnormal brain activity. This medication is often prescribed when other treatments have not been effective. Tiagabine Hydrochloride 16 mg tablets are designed for oral administration and are intended to be taken as directed by a healthcare provider.

Common effects of Tiagabine Hydrochloride may include dizziness, drowsiness, and fatigue. Some users may also experience nausea, tremor, or difficulty concentrating. These effects can vary from person to person and may improve over time as the body adjusts to the medication. It is important to monitor any persistent or severe side effects and consult a healthcare professional if necessary.

Tiagabine Hydrochloride should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication may cause drowsiness, so it is advisable to avoid activities that require alertness until the effects are known. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Tiagabine Hydrochloride may interact with other medications, including those that affect the central nervous system. Alcohol and certain antidepressants can enhance the sedative effects of Tiagabine. It is also important to be cautious with medications that inhibit or induce liver enzymes, as they can affect the metabolism of Tiagabine. Always consult a healthcare professional before starting or stopping any medication while taking Tiagabine Hydrochloride.